Medicine and Dentistry
Lysophosphatidic Acid Receptor
100%
Spinal Cord Injury
81%
Amyotrophic Lateral Sclerosis
81%
Lysophosphatidic Acid
27%
Combination Therapy
27%
Skeletal Muscle
27%
Receptor
22%
Gene Deletion
18%
Muscle Atrophy
18%
Spinal Cord
18%
Diseases
18%
Serositis
18%
IC50
13%
Disability
13%
Antiinflammatory Agent
13%
Injury
13%
Surgical Decompression
13%
Peripheral Nerve
9%
Demyelination
9%
Lipid
9%
Degeneration
9%
Axon
9%
Sciatic Nerve
9%
Neural Stem Cell
9%
Lifespan
9%
Pathophysiology
9%
RNA
9%
Survival
9%
Programmed Cell Death
9%
Astrocytosis
9%
G Protein Coupled Receptor
9%
Myositis
9%
Cell Function
9%
Deterioration
9%
Central Nervous System
9%
Motoneuron
9%
Introspection
9%
Mediator
9%
Patient
9%
Macrophage
9%
Pharmacology, Toxicology and Pharmaceutical Science
Lysophosphatidic Acid Receptor
100%
Spinal Cord Injury
81%
Antagonist
81%
Amyotrophic Lateral Sclerosis
81%
Mouse
50%
Lysophosphatidic Acid
27%
Mouse Model
22%
Receptor
22%
Inflammation
18%
Muscle Atrophy
18%
Diseases
18%
IC50
13%
Antiinflammatory Agent
13%
Injury
13%
Disability
13%
Lipid
9%
Pathophysiology
9%
Myositis
9%
Survival
9%
Death
9%
Demyelination
9%
Astrocytosis
9%
Deterioration
9%
Animal
9%
RNA
9%
Immunology and Microbiology
Mouse
36%
Inflammation
27%
Skeletal Muscle
27%
Spinal Cord
18%
Gene Deletion
18%
Lifespan
9%
Survival
9%
Mouse Model
9%
Sample
9%
Muscle
9%
Introspection
9%
Mediator
9%
Sciatic Nerve
9%
Axon
9%
Motoneuron
9%
Peripheral Nerve
9%
Central Nervous System
9%
Animal
9%
Cell Function
9%